2006-05-01
Non-invasive measurement of liver fibrosis: Application of the FibroScan® in hepatology
Publication
Publication
Scandinavian Journal of Gastroenterology , Volume 41 - Issue SUPPL. 243 p. 85- 88
The liver biopsy is still regarded as the gold standard for the assessment of liver disease. However, there is a growing demand for non-invasive assessment of liver fibrosis, which is the most important prognostic factor in chronic liver disease, in particular in viral hepatitis. Transient elastography is a novel, non-invasive and rapid bedside method for assessing liver fibrosis by measuring liver stiffness. Some recent extensive studies, mainly from France, have demonstrated that measurement with the FibroScan® is a good alternative for the liver biopsy. The amount of fibrosis can be quantified very easily and reliably. In this review, we describe the technique and discuss the available studies in order to establish applicability and to provide points for discussion.
Additional Metadata | |
---|---|
, , , | |
doi.org/10.1080/00365520600664359, hdl.handle.net/1765/74398 | |
Scandinavian Journal of Gastroenterology | |
Organisation | Department of Gastroenterology & Hepatology |
Verveer, C., & de Knegt, R. (2006). Non-invasive measurement of liver fibrosis: Application of the FibroScan® in hepatology. In Scandinavian Journal of Gastroenterology (Vol. 41, pp. 85–88). doi:10.1080/00365520600664359 |